CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −3,907 | 0 | ||
| 2026-02-24 | Kirby Daniel Gordon Chief Commercial Officer | Option exercise | +120,000 | 173,546 | ||
| 2026-02-24 | Kirby Daniel Gordon Chief Commercial Officer | Shares withheld for taxes | −34,165 | $3.78 | $129K | 139,381 |
| 2026-02-24 | Kirby Daniel Gordon Chief Commercial Officer | Option exercise · Restricted Stock Units | −150,000 | 0 | ||
| 2026-02-10 | Kirby Daniel Gordon Chief Commercial Officer | Option exercise | +39,996 | 69,996 | ||
| 2026-02-10 | Kirby Daniel Gordon Chief Commercial Officer | Shares withheld for taxes | −16,450 | $2.60 | $43K | 53,546 |
| 2026-02-10 | Kirby Daniel Gordon Chief Commercial Officer | Option exercise · Restricted Stock Units | −39,996 | 80,004 | ||
| 2025-12-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +3,906 | 113,640 | ||
| 2025-12-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,984 | $2.14 | $4K | 111,656 |
| 2025-12-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −3,906 | 3,907 | ||
| 2025-12-02 | BILINSKY IGOR Chief Operating Officer | Option exercise | +3,516 | 107,530 | ||
| 2025-12-02 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,786 | $2.14 | $4K | 105,744 |
| 2025-12-02 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −3,516 | 3,517 | ||
| 2025-12-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +10,417 | 468,948 | ||
| 2025-12-02 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −4,426 | $2.14 | $9K | 464,522 |
| 2025-12-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −10,417 | 10,418 | ||
| 2025-12-01 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +8,789 | 114,198 | ||
| 2025-12-01 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −4,464 | $2.23 | $10K | 109,734 |
| 2025-12-01 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −8,789 | 43,949 | ||
| 2025-12-01 | BILINSKY IGOR Chief Operating Officer | Option exercise | +8,789 | 108,478 |
Page 6 of 14 · 280 trades